Pierre Fabre
Thomas Landemaine is an accomplished professional with extensive experience in financial analysis and corporate business development within the biotech and healthcare sectors. Currently serving as the Head of Financial Analysis at Pierre Fabre Group since January 2020, Thomas has previously held significant roles, including Senior Equity Research Analyst at Kepler Cheuvreux and Financial Analyst at CM-CIC Market Solutions, where coverage included various biotech and medtech companies. With a solid foundation in marketing and project management from previous positions at Nordic Pharma Group and Capgemini Consulting, Thomas also has a strong academic background, holding a PhD in Molecular Biology and an MBA in Management.
This person is not in any teams
This person is not in any offices
Pierre Fabre
15 followers
Pierre Fabre Group, also known as Laboratoires Pierre Fabre, operates as a pharmaceutical company in France and internationally.